Ofron Eye/Ear Drops contain Ofloxacin 0.3% w/v, a broad-spectrum fluoroquinolone antibiotic effective against a wide range of gram-positive and gram-negative bacteria. This medication is indicated for the treatment of bacterial infections of the eye and ear, including conjunctivitis, keratitis, blepharitis, otitis externa, and otitis media. Ofloxacin acts by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for bacterial DNA replication, transcription, repair, and recombination, thereby exerting a bactericidal effect. Ofron Eye/Ear Drops are formulated for topical administration, allowing direct delivery of the active ingredient to the site of infection, ensuring rapid onset of action and minimizing systemic absorption. The drops are generally well tolerated; however, patients may experience mild transient irritation, burning, or stinging upon instillation. It is important to use the medication as prescribed and complete the full course of treatment to prevent the development of antibiotic resistance. Contraindications include hypersensitivity to ofloxacin or other quinolones. Caution is advised in patients with a history of hypersensitivity reactions to fluoroquinolones. Ofron Eye/Ear Drops should not be used in viral or fungal infections unless there is a secondary bacterial infection. Proper hygiene and administration techniques are essential to avoid contamination and ensure therapeutic efficacy.